Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.
about
Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancerIndependent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancerGenetic alteration and gene expression modulation during cancer progressionEvaluation of the similarity of gene expression data estimated with SAGE and Affymetrix GeneChipsNucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical SensingExploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysBiomarker discovery from pancreatic cancer secretome using a differential proteomic approachBioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkersPancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets.New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs).Overexpressed Claudin-1 Can Be Visualized Endoscopically in Colonic Adenomas In Vivo.Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection.Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays.Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma.Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma.Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade.Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality.Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.MicroRNA alterations of pancreatic intraepithelial neoplasiasTrop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.Genetics and pathology of pancreatic cancer.Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarraysCD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture.Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer.Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathwayGenomics and the search for novel biomarkers in toxicology.Role of tissue stroma in cancer cell invasion.A multistep high-content screening approach to identify novel functionally relevant target genes in pancreatic cancer.Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses.Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.Identification of novel cellular targets in biliary tract cancers using global gene expression technology.Proteomic profiling of pancreatic cancer for biomarker discovery.Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications.Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinomaOverexpression of annexin 1 in pancreatic cancer and its clinical significance.
P2860
Q24337345-241A2B93-0FF5-471B-8A54-D58DB9C12EC3Q24656609-D8576BD1-B9C7-4BFF-8F13-398C08F4542DQ24798750-E5EF1C1F-69FB-42D7-9DA0-92E955235193Q24813318-EEEE2795-F16A-46DF-8D63-7D4C64A6FAC7Q26825644-1EAA9CC7-C255-42A7-B12A-63232B74F34CQ28185685-F5A8547C-BDA7-4689-ADE5-6061A3FCA69EQ28276398-9AA63524-A764-470B-BD92-4945A36A5812Q28834154-B13C8058-C20D-42BB-8091-3E6307A7EFA2Q30483618-FC041509-3130-4938-AB40-E3F8FD131A02Q30489770-D5EFA60A-0CF0-4432-97E9-E1BC343E2E1DQ30534663-0FD4D20B-63DB-4939-9FF6-089BB07C5D03Q30797702-6D9C97ED-04FA-4348-89A9-0A38C0F1685FQ31041732-3A1CE546-725B-4EA4-A73D-EA553DC7C522Q31121505-6C731848-696C-447C-A9D1-B6E509D2F848Q31156199-C914535C-EC15-40CC-9119-8F730114FB0EQ33234488-D86F38AC-9A49-4069-AE30-1D451950E1BFQ33280569-DED4F77F-F78F-4861-A388-A361FEC055A8Q33391858-66320E9E-00F1-4DD2-9E6C-48302E444E1FQ33531856-A77B31F7-C531-445D-900F-BD58FCC00BC7Q33862088-443CF528-5BE7-4EB8-ACF8-E00DE88464A9Q33992146-D01049AC-A3F1-453C-8D17-D4CD2068B18FQ34082610-7D7F4DC9-13FE-4950-905D-087A55C3340DQ34476583-BFB8C71F-944C-4AE6-9188-9B2B82ADE185Q34589293-45AFA4C2-DF25-4422-9C17-6E611D05C5ECQ34928555-1F50C762-FCCE-470A-84BF-37E5AC32F559Q35017547-0BEDA396-3F87-4D83-990E-64112278E23FQ35032539-3F25669A-5800-4C88-B149-029A8F809B52Q35094629-515A30F7-F173-4150-BEB0-B0BD908BD898Q35099833-03749AC8-E141-40B7-89F4-29F311CEF6BAQ35140486-90876486-FE1D-485E-8B29-B4FA9B2697E8Q35170428-51FF10CC-2568-48A9-93EF-F83F0EBC723DQ35304445-31C9583E-A8B1-406C-AD80-365DCFCACB54Q35576601-732B9306-7FCA-4D3F-A776-4D596DDCEDD7Q35588895-5C865F9D-6995-4B4F-A13A-8EE63FE3BBF3Q35627068-27A9BE42-2639-4F34-8781-D391B62934ADQ35791572-9F5826E8-CA82-4529-BC70-435685D71F4FQ36026306-FFD799A1-63D3-488B-A2CA-6FC50902E33CQ36032931-2E895A83-F83C-4F91-BB1E-0BA5811ED58AQ36124027-6D6F533A-8EC3-4D88-A965-5CC26F821CFAQ36308123-802C3BC0-DFE5-478D-BFA9-E3371C7439B0
P2860
Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Discovery of novel tumor marke ...... al gene expression technology.
@ast
Discovery of novel tumor marke ...... al gene expression technology.
@en
type
label
Discovery of novel tumor marke ...... al gene expression technology.
@ast
Discovery of novel tumor marke ...... al gene expression technology.
@en
prefLabel
Discovery of novel tumor marke ...... al gene expression technology.
@ast
Discovery of novel tumor marke ...... al gene expression technology.
@en
P2093
P2860
P50
P1476
Discovery of novel tumor marke ...... al gene expression technology.
@en
P2093
Anirban Maitra
Charles J Yeo
Grace L Shen-Ong
John L Cameron
Karin Berg
Kimberly Walter
Michael A Hollingsworth
Raheela Ashfaq
Renee Meyer
Scott E Kern
P2860
P304
P356
10.1016/S0002-9440(10)62551-5
P407
P577
2002-04-01T00:00:00Z